For pharmaceutical companies, the growing trend of off-label prescribing presents both opportunities and challenges
Contrave combines bupropion and naltrexone, working on brain reward pathways rather than GLP-1 receptors
Real-World Data Says Otherwise Click2Pharmacy, Mounjaro Statistics 2025 KFF, KFF Health Tracking Poll 2024: The Publics Use of GLP-1 Drugs CNN, Certain Obesity Drugs Will Cost as Little as $149 and Medicare Will Start Covering Them Under White House Deals Drugs4Delivery, Mounjaro and Wegovy Price Changes Coming September 2025 Delve Insight, 9 Promising Obesity Drugs Set To Launch by 2030 Pfizer, Pfizer to Acquire Metsera and Its Next Generation Obesity Portfolio Morning Star, Two Companies Poised to Capitalize on the Rise of GLP-1 Drugs
13 Ask if the patient is experiencing, or has ever experienced, nausea and vomiting because of the GLP-1 receptor agonist therapy, and if so, document this information in the patient record
Oral GLP-1 Medications For those who prefer not to use injections, oral GLP-1 medications are another option, though they may not be as effective for significant weight loss
10.1038/nrendo.2015.51 36
